Debate: PhRMA and its relations with Gov, Academia, Doctors and Consumers_Oct 4-5
Two especially timely conferences focus on MEDICINE AND THE LAW:
Two especially timely conferences focus on MEDICINE AND THE LAW:
“a study published yesterday overturns conventional wisdom about antipsychotic drugs, which cost the United States $10 billion a year.”
Stanford University announced that it is adopting a strict conflicts of interest policy.
AIR: America’s Investigative Reports, is a new Public Broadcasting System (PBS) series whose first report, "A Bitter Pill," airs Friday, Sept. 8.
Psychiatry’s most powerful and influential key opinion leaders who belong to the American College of Neuropsychopharmacology (ACNP) have been caught off guard. The ACNP leadership is scrambling to overcome the scorn it has received following public disclosure about multiple breaches of ethics and professional standards of conduct. The College and…
USA Today reports that last year the pharmaceutical industry "faced the most product liability lawsuits of any other industry."
A Boston Globe report (below) focuses on three recent reports in the Journal of the American Medical Association (JAMA) by Harvard researchers who violated the journal’s disclosure policy by failing to disclose their financial ties to companies that had the most to gain from their purported findings.
"Even though clinical research is a noble and worthy activity, it’s very easy to lose your moral compass if your primary goal is the dollar amount of grant funding that you generate."
Steven Potkin, who, LAT reports, is a brother-in-law of Jane Pauley who wrapped up her career as TV news anchor to become a paid drug pusher.
The harm done by journals’ failure to protect the integrity of science can hardly be overstated.
Today’s New York Times editorial hits the mark–it’s right on target!
The Greatest Benefit to Mankind: A Medical History of Humanity from Antiquity to the Present , by Professor Roy Porter , Fontana, Press , 1997. Below are a few–still very relevant–quotes…